Home
Transgene Biotek Ltd Share Price History
Transgene Biotek Ltd
BSE : 17 Jan, 2025
4.950.2 (4.4%)
Prev Close
4.7
Open Price
4.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
36400
Today's High / Low
5.0 / 4.9
52 WK High / Low
12.5 / 3.9
Market Price of Transgene Biotek Ltd
1M
1Y
3Y
5Y
Monitoring Transgene Biotek Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 0 |
| YoY Gr. | - |
| Net Profit (Cr.) | -20 |
| BVPS | 7.77 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 0 |
| Op. Profit Mgn % | -512.9 |
| Net Profit Mgn % | -6174.19 |
| Debt to Equity % | 0.07 |
Latest Shareholding
Promoters Holdings Over Time
About Transgene Biotek Ltd
- Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
- Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
- The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.
FAQs for Transgene Biotek Ltd Share Price History
What are the key events that typically impact Transgene Biotek Ltd's share price history?
Key events that impact Transgene Biotek Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Transgene Biotek Ltd's share price history?
Stock splits reduce the nominal price of Transgene Biotek Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Transgene Biotek Ltd?
Dividends can influence Transgene Biotek Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Transgene Biotek Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Transgene Biotek Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Transgene Biotek Ltd’s share price history?
To understand Transgene Biotek Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
